1. Home
  2. CELU vs CAPT Comparison

CELU vs CAPT Comparison

Compare CELU & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • CAPT
  • Stock Information
  • Founded
  • CELU 2016
  • CAPT 2005
  • Country
  • CELU United States
  • CAPT South Korea
  • Employees
  • CELU N/A
  • CAPT N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • CELU Health Care
  • CAPT Finance
  • Exchange
  • CELU Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • CELU 49.9M
  • CAPT 41.9M
  • IPO Year
  • CELU N/A
  • CAPT N/A
  • Fundamental
  • Price
  • CELU $2.24
  • CAPT $0.67
  • Analyst Decision
  • CELU
  • CAPT
  • Analyst Count
  • CELU 0
  • CAPT 0
  • Target Price
  • CELU N/A
  • CAPT N/A
  • AVG Volume (30 Days)
  • CELU 231.0K
  • CAPT 327.5K
  • Earning Date
  • CELU 11-07-2024
  • CAPT 01-01-0001
  • Dividend Yield
  • CELU N/A
  • CAPT N/A
  • EPS Growth
  • CELU N/A
  • CAPT N/A
  • EPS
  • CELU N/A
  • CAPT N/A
  • Revenue
  • CELU $48,200,000.00
  • CAPT $17,389,944.00
  • Revenue This Year
  • CELU N/A
  • CAPT N/A
  • Revenue Next Year
  • CELU $233.89
  • CAPT N/A
  • P/E Ratio
  • CELU N/A
  • CAPT N/A
  • Revenue Growth
  • CELU 225.94
  • CAPT 84.70
  • 52 Week Low
  • CELU $1.30
  • CAPT $0.65
  • 52 Week High
  • CELU $7.97
  • CAPT $7.92
  • Technical
  • Relative Strength Index (RSI)
  • CELU 46.60
  • CAPT 33.93
  • Support Level
  • CELU $2.17
  • CAPT $0.65
  • Resistance Level
  • CELU $2.43
  • CAPT $0.99
  • Average True Range (ATR)
  • CELU 0.26
  • CAPT 0.11
  • MACD
  • CELU -0.01
  • CAPT 0.00
  • Stochastic Oscillator
  • CELU 54.02
  • CAPT 2.46

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: